October 29, 2009

Bioftalmik patents an innovative non-invasive limbic insufficiency diagnosis system

Bioftalmik, a Basque biotechnology company specialised in the ophthalmology field, has patented an innovative non-invasive diagnosis system to detect limbic insufficiency. The new diagnosis developed by Bioftalmik is of a molecular nature, and there is no place for human interpretation. It is more sensitive and specific than conventional impression cytology, does not provide false results,...
Read More